Andere Sprachen Bio Plus Co., Ltd

Aktien

A099430

KR7099430001

A099430

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 28.06.2024			% 5 Tage	% 1. Jan.
5 580 ^KRW	+1,82 %		+9,84 %	-18,78 %

10.06.	Bio Plus Co., Ltd (KOSDAQ:A099430) kündigt einen Aktienrückkauf im Wert von 5.000 Millionen KRW an.	CI
10.06.	Bio Plus Co., Ltd autorisiert einen Rückkaufplan.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio Plus Co., Ltd announces an Equity Buyback for KRW 5,000 million worth of its shares.	10.06.
Bio Plus Co., Ltd authorizes a Buyback Plan.	10.06.
Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat	24.01.
Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains	24.01.
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09.11.
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09.11.
BioPlus Co., Ltd.'s Equity Buyback announced on May 9, 2023, has expired with 743,436 shares, representing 1.28% for ¥4,990.07 million.	08.11.
Elevance Health Lifts Full-Year Earnings Outlook as Third-Quarter Results Rise	18.10.23
Elevance Health 3Q Revenue Rises on Higher Premiums	18.10.23
BioPlus Acquisition, Avertix Medical Terminate Business Combination Deal	04.10.23
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09.08.23
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	09.05.23
BioPlus Co., Ltd. authorizes a Buyback Plan.	09.05.23
BioPlus Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23.03.23
Elevance Health to Acquire Specialty Pharmacy BioPlus for Undisclosed Sum	09.11.22
BioPlus to Raise $14.2 Million from Share Sale; Shares Jump 4%	06.10.22
BioPlus Co., Ltd. announced that it expects to receive KRW 19.99996275 billion in funding	06.10.22
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on December 7, 2021.	08.06.22
BioPlus Co., Ltd.'s Equity Buyback announced on December 7, 2021, has expired with 199,320 shares, representing 1.43% for KRW 4,987.71 million.	07.06.22
BioPlus Co., Ltd.'s Equity Buyback announced on October 13, 2021, has expired.	13.04.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio Plus Co., Ltd

Aktien

A099430

KR7099430001

A099430

Andere Sprachen

Filter